¼¼°èÀÇ ¿äõÃß ½Å°æ±Ù ÅëÁõ ½ÃÀå º¸°í¼­(2025³â)
Lumbosacral Radicular Pain Global Market Report 2025
»óǰÄÚµå : 1769644
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,310,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,121,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,932,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿äõÃß ½Å°æ±Ù ÅëÁõ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµÉ ¿¹Á¤ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀå Àü¸ÁÀº ÅëÁõ °ü¸® ±â¼úÀÇ ¹ßÀü, ºñ¿ÀÇÇ¿ÀÀ̵å Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ °­Á¶ Áõ°¡, ôÃß ¿¬±¸ ¹× °³¹ß¿¡ ´ëÇÑ ÅõÀÚ È®´ë, ¿Ü·¡ ¹× ÃÖ¼Ò Ä§½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÀÇ·á Á¢±Ù¼º °³¼± µî¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÃÖ¼Ò Ä§½À ¼ö¼ú ±â¼úÀÇ ¹ßÀü, Ç¥Àû Ç׿°ÁõÁ¦ °³¹ß, ¿þ¾î·¯ºí ÅëÁõ °ü¸® ±â±âÀÇ Çõ½Å, ½Å°æ±ÙÀ» ½Äº°Çϱâ À§ÇÑ Ã·´Ü ¿µ»ó ¹æ¹ý, ȯÀÚº° µ¥ÀÌÅÍ¿¡ ±â¹ÝÇÑ °³ÀÎ ¸ÂÃãÇü Ä¡·á °èȹÀÇ ¼ö¸³ µîÀÌ ÀÖ½À´Ï´Ù.

ÅðÇ༺ ôÃß ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¾ÕÀ¸·Î ¸î ³â µ¿¾È ¿äÃߺΠ½Å°æ±Ù ÅëÁõ ½ÃÀåÀÌ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÅðÇ༺ ôÃß ÁúȯÀº ½Ã°£ÀÌ Áö³²¿¡ µû¶ó ôÃß°¡ Á¡ÁøÀûÀ¸·Î ¾ÇÈ­µÇ¾î ¹ß»ýÇÏ´Â ´Ù¾çÇÑ ÁúȯÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Áõ°¡´Â ÁÖ·Î Àα¸ °í·ÉÈ­¿Í ôÃß ÅðÇà ¹× ½Å°æ ¾Ð¹Ú¿¡ ±â¿©ÇÏ´Â »ýȰ ½À°ü ¿äÀο¡ ÀÇÇØ ÃËÁøµÇ¸ç, ÀÌ·Î ÀÎÇØ È¿°úÀûÀÎ Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿äÃߺΠ½Å°æ±Ù ÅëÁõÀº ½Å°æ±ÙÀÇ ÀÚ±ØÀ̳ª ¾Ð¹ÚÀ» °­Á¶ÇÏ¿© ±Ùº»ÀûÀÎ ÅðÇ༺ ôÃß ¹®Á¦¸¦ ³ªÅ¸³»´Â ÁöÇ¥·Î ÀÛ¿ëÇÏ¿© ÀÓ»ó Æò°¡ ¹× Ä¡·á °èȹ¿¡ µµ¿òÀÌ µË´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 5¿ù, È£ÁÖ¿¡ ÀÖ´Â °ø¸³ ´ëÇÐÀÎ ½Ãµå´Ï ´ëÇÐÀº 2050³â±îÁö Àü ¼¼°èÀûÀ¸·Î 8¾ï ¸í ÀÌ»óÀÇ »ç¶÷µéÀÌ ¿äÅëÀ» °æÇèÇÒ °ÍÀ¸·Î Àü¸ÁÇß½À´Ï´Ù. ±× °á°ú, ÅðÇ༺ ôÃß ÁúȯÀÇ ¹ßº´·üÀÌ Áõ°¡ÇÏ´Â °ÍÀÌ ¿äÃߺΠ½Å°æ±Ù ÅëÁõ ½ÃÀåÀÇ È®ÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¿äõÃß ½Å°æ±Ù ÅëÁõ ½ÃÀå ¼±µµ ±â¾÷µéÀº ÅëÁõ ¿ÏÈ­¿Í ȯÀÚ ÆíÀǼºÀ» Çâ»ó½Ã۱â À§ÇØ ¼ÒÇüÈ­µÇ°í ÀçÃæÀü °¡´ÉÇÑ Ã´¼ö ÀÚ±Ø(SCS) ½Ã½ºÅÛ µî °í±Þ ÃÖ¼Ò Ä§½ÀÀû ½Å°æ Á¶Àý Ä¡·á¹ý °³¹ßÀ» ¿ì¼±¼øÀ§·Î µÎ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ÒÇüÈ­ µÈ SCS ÀåÄ¡´Â ô¼ö¿¡ Àü±âÀû Ãæ°ÝÀ» Àü´ÞÇÏ¿© ÅëÁõ ½ÅÈ£¸¦ Â÷´ÜÇϸç, Àå½Ã°£ ¹èÅ͸® ¼ö¸í°ú ´ú ħ½ÀÀûÀÎ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 12¿ù ¹Ì±¹ ±â¹Ý ÀÇ·á ±â¾÷ÀÎ Abbott Laboratories´Â ¸¸¼º ÅëÁõ °ü¸®¿ë °í±Þ BurstDR Ä¡·á¸¦ Á¦°øÇÏ´Â Eterna ôÃß ÀÚ±Ø ½Ã½ºÅÛÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ÃæÀü »çÀÌÀÇ ½Ã°£À» Å©°Ô ¿¬ÀåÇØ ȯÀÚÀÇ ºÒÆíÀ» ÁÙÀÌ´Â ÃֽŠÀçÃæÀü½Ä ¹èÅ͸® ±â¼úÀ» Ư¡À¸·Î ÇÕ´Ï´Ù. ¶ÇÇÑ ÀÚ¿¬½º·¯¿î ½Å°æ Ȱµ¿À» ¸ð¹æÇØ ´õ È¿°úÀûÀ̰í Áö¼ÓÀûÀÎ ÅëÁõ ¿ÏÈ­¸¦ Á¦°øÇÏ´Â µ¶Á¡Àû ÀÚ±Ø ÆÐÅÏÀÎ BurstDRÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ÀåÄ¡´Â MRI ȣȯÀÌ °¡´ÉÇØ ȯÀÚ°¡ ÀåÄ¡¸¦ Á¦°ÅÇÏÁö ¾Ê°í Àü½Å ½ºÄµÀ» ¾ÈÀüÇÏ°Ô ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ µðÀÚÀÎÀÌ ¾÷±×·¹À̵å ģȭÀûÀ̾ ȯÀÚ°¡ Ãß°¡ ¼ö¼ú ¾øÀÌ ¹Ì·¡ ±â¼ú °³¼±À» ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª 19 ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°, ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Lumbosacral radicular pain is a type of pain that begins in the lower spine (lumbar and sacral areas) and travels along the course of a spinal nerve into the leg. It is most often caused by compression or irritation of the nerve root, typically resulting from conditions like a herniated disc or spinal stenosis.

The primary categories of treatment for lumbosacral radicular pain include pharmacological therapies, non-pharmacological approaches, and interventional procedures. Pharmacological therapies involve the use of drugs or medications to diagnose, manage, or prevent health conditions. These medications can be administered through various methods, including oral, topical, injectable, and implantable routes. The distribution of these drugs occurs through different channels such as hospital pharmacies, retail pharmacies, and online pharmacies, serving a range of end-users including hospitals, specialty clinics, rehabilitation centers, and homecare environments.

The lumbosacral radicular pain market research report is one of a series of new reports from The Business Research Company that provides lumbosacral radicular pain market statistics, including the lumbosacral radicular pain industry global market size, regional shares, competitors with the lumbosacral radicular pain market share, detailed lumbosacral radicular pain market segments, market trends, and opportunities, and any further data you may need to thrive in the lumbosacral radicular pain industry. This lumbosacral radicular pain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lumbosacral radicular pain market size has grown strongly in recent years. It will grow from $0.91 billion in 2024 to $0.97 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth during the historic period can be credited to the rising prevalence of lower back disorders, a growing elderly population experiencing spinal problems, an increase in sedentary lifestyles and poor posture, heightened demand for pain management treatments, and greater awareness regarding early diagnosis and intervention.

The lumbosacral radicular pain market size is expected to see strong growth in the next few years. It will grow to $1.21 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The projected growth in the forecast period can be attributed to advancements in pain management technologies, a growing emphasis on non-opioid treatment alternatives, increased investment in spinal research and development, rising demand for outpatient and minimally invasive procedures, and improved access to healthcare in emerging markets. Key trends expected during this period include progress in minimally invasive surgical techniques, the development of targeted anti-inflammatory medications, innovations in wearable pain management devices, advanced imaging methods for identifying nerve roots, and the creation of personalized treatment plans based on patient-specific data.

The rising prevalence of degenerative spinal conditions is anticipated to drive the growth of the lumbosacral radicular pain market in the coming years. Degenerative spinal conditions encompass a range of disorders resulting from the progressive deterioration of the spine over time. This increase is primarily driven by aging populations and lifestyle factors that contribute to spinal degeneration and nerve compression, leading to greater demand for effective diagnosis and treatment. Lumbosacral radicular pain serves as an indicator of underlying degenerative spinal issues by highlighting nerve root irritation or compression, thereby aiding clinical assessment and treatment planning. For example, in May 2023, the University of Sydney, an Australia-based public university, projected that over 800 million people globally will experience back pain by 2050. As a result, the growing incidence of degenerative spinal conditions is a key factor fueling the expansion of the lumbosacral radicular pain market.

Leading companies in the lumbosacral radicular pain market are prioritizing the development of advanced minimally invasive neuromodulation therapies, including compact and rechargeable spinal cord stimulation (SCS) systems, to improve pain relief and enhance patient comfort. These miniaturized SCS devices are implantable and deliver electrical impulses to the spinal cord to disrupt pain signals, providing extended battery life and less invasive treatment options. For example, in December 2022, Abbott Laboratories, a U.S.-based healthcare company, introduced the Eterna spinal cord stimulation system designed to deliver advanced BurstDR therapy for chronic pain management. This system features state-of-the-art rechargeable battery technology that significantly lengthens the time between recharges, reducing inconvenience for patients. It also includes proprietary stimulation patterns, such as BurstDR, that replicate natural nerve activity for more effective and sustained pain relief. Additionally, the device is MRI-compatible, allowing patients to safely undergo full-body scans without device removal. Its design is also upgrade-friendly, enabling patients to access future technological improvements without requiring further surgeries.

In October 2024, Stryker Corporation, a U.S.-based medical technology company, acquired Vertos Medical Inc. for an undisclosed sum. This acquisition is intended to bolster Stryker's portfolio of minimally invasive spine treatments by incorporating Vertos Medical's innovative technologies, improving patient outcomes, and reinforcing its position as a leader in the spinal health market. Vertos Medical Inc. is a U.S.-based company focused on minimally invasive treatments for lumbar spinal stenosis (LSS).

Major players in the lumbosacral radicular pain market are Pfizer Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Eli Lilly and Company, Boston Scientific Corporation, Vertex Pharmaceuticals, Biotronik, Nevro Corp., Sorrento Therapeutics, Scilex Holding Company, ProMed Pharma, SPR Therapeutics, Saluda Medical Pty Ltd., Eliem Therapeutics, Cephalon Inc., Semnur Pharmaceuticals Inc., Nalu Medical Inc., Sollis Therapeutics Inc.

North America was the largest region in the lumbosacral radicular pain market in 2024. The regions covered in lumbosacral radicular pain report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lumbosacral radicular pain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lumbosacral radicular pain market includes revenues earned by entities by providing services such as non-surgical treatment services, interventional pain management services, and rehabilitation and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lumbosacral Radicular Pain Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lumbosacral radicular pain market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for lumbosacral radicular pain ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lumbosacral radicular pain market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Lumbosacral Radicular Pain Market Characteristics

3. Lumbosacral Radicular Pain Market Trends And Strategies

4. Lumbosacral Radicular Pain Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lumbosacral Radicular Pain Growth Analysis And Strategic Analysis Framework

6. Lumbosacral Radicular Pain Market Segmentation

7. Lumbosacral Radicular Pain Market Regional And Country Analysis

8. Asia-Pacific Lumbosacral Radicular Pain Market

9. China Lumbosacral Radicular Pain Market

10. India Lumbosacral Radicular Pain Market

11. Japan Lumbosacral Radicular Pain Market

12. Australia Lumbosacral Radicular Pain Market

13. Indonesia Lumbosacral Radicular Pain Market

14. South Korea Lumbosacral Radicular Pain Market

15. Western Europe Lumbosacral Radicular Pain Market

16. UK Lumbosacral Radicular Pain Market

17. Germany Lumbosacral Radicular Pain Market

18. France Lumbosacral Radicular Pain Market

19. Italy Lumbosacral Radicular Pain Market

20. Spain Lumbosacral Radicular Pain Market

21. Eastern Europe Lumbosacral Radicular Pain Market

22. Russia Lumbosacral Radicular Pain Market

23. North America Lumbosacral Radicular Pain Market

24. USA Lumbosacral Radicular Pain Market

25. Canada Lumbosacral Radicular Pain Market

26. South America Lumbosacral Radicular Pain Market

27. Brazil Lumbosacral Radicular Pain Market

28. Middle East Lumbosacral Radicular Pain Market

29. Africa Lumbosacral Radicular Pain Market

30. Lumbosacral Radicular Pain Market Competitive Landscape And Company Profiles

31. Lumbosacral Radicular Pain Market Other Major And Innovative Companies

32. Global Lumbosacral Radicular Pain Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lumbosacral Radicular Pain Market

34. Recent Developments In The Lumbosacral Radicular Pain Market

35. Lumbosacral Radicular Pain Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â